Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Dirigidas en Enfermedades Reumáticas

Biobadaser Fase III

One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registry

23/05/2025

López-Medina, C., et al.

Reum Clin 2025 (Online)

https://doi.org/10.1016/j.reuma.2025.501872

doi: 10.1016/j.reuma.2025.501872